Document is current
Any future updates will be listed below
-
Authors
O’Gallagher, Kevin
Shek, Anthony
Bean, Daniel M.
Bendayan, Rebecca
Papachristidis, Alexandros
Teo, James T. H.
Dobson, Richard J. B.
Shah, Ajay M.
Zakeri, Rosita http://orcid.org/0000-0002-4225-3693
-
Funding
Funding for this research was provided by:
British Heart Foundation (CH/1999001/11735 and RE/18/2/34213)
NIHR BRC GSTT (IS-BRC-1215-20006)
NIHR BRC South London & Maudsley (IS-BRC-1215-20018)
King's College London (Prize Fellowship)
Fondation Leducq
Medical Research Council (MR/R016372/1)
King's Medical Research Trust
HDRUK (HDRUK MR/S00310X/1.)
UKRI
NIHR BRC UCL
- License Information
-
More Information
Article History
Received: 7 March 2021
Accepted: 24 June 2021
First Online: 3 July 2021
Declarations
:
: This study was conducted under London South East Research Ethics Committee approval (reference 18/LO/2048) granted to the King’s Electronic Records Research Interface (KERRI) for collection of clinically relevant data from patients’ electronic health records. Individual patient written consent was not required, however, COVID-19 work was reviewed with expert patient input on a virtual committee with Caldicott Guardian oversight.
: Not applicable.
: JTHT received research funding from Innovate UK & Office of Life Sciences, and iRhythm Technologies, and holds shares < £5,000 in Glaxo Smithkline and Biogen. The other authors declare no competing interests.
